212 related articles for article (PubMed ID: 10845832)
1. Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis.
Tanawattanacharoen S; Falk RJ; Jennette JC; Kopp JB
Am J Kidney Dis; 2000 Jun; 35(6):1166-74. PubMed ID: 10845832
[TBL] [Abstract][Full Text] [Related]
2. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy.
Moudgil A; Nast CC; Bagga A; Wei L; Nurmamet A; Cohen AH; Jordan SC; Toyoda M
Kidney Int; 2001 Jun; 59(6):2126-33. PubMed ID: 11380814
[TBL] [Abstract][Full Text] [Related]
3. [Collapsing variant of focal segmental glomerulosclerosis by parvovirus B19: case report].
Freitas GR; Praxedes MR; Malheiros D; Testagrossa L; Dias CB; Woronik V
J Bras Nefrol; 2015; 37(1):121-6. PubMed ID: 25923759
[TBL] [Abstract][Full Text] [Related]
4. Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants.
Swaminathan S; Lager DJ; Qian X; Stegall MD; Larson TS; Griffin MD
Nephrol Dial Transplant; 2006 Sep; 21(9):2607-14. PubMed ID: 16705026
[TBL] [Abstract][Full Text] [Related]
5. Collapsing glomerulopathy in a young woman with APOL1 risk alleles following acute parvovirus B19 infection: a case report investigation.
Besse W; Mansour S; Jatwani K; Nast CC; Brewster UC
BMC Nephrol; 2016 Sep; 17(1):125. PubMed ID: 27600725
[TBL] [Abstract][Full Text] [Related]
6. Molecular identification of SV40 infection in human subjects and possible association with kidney disease.
Li RM; Branton MH; Tanawattanacharoen S; Falk RA; Jennette JC; Kopp JB
J Am Soc Nephrol; 2002 Sep; 13(9):2320-30. PubMed ID: 12191976
[TBL] [Abstract][Full Text] [Related]
7. HIV-associated nephropathy: experimental models.
Avila-Casado C; Fortoul TI; Chugh SS
Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
[TBL] [Abstract][Full Text] [Related]
8. Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: a 20-year renal biopsy study.
Haas M; Spargo BH; Coventry S
Am J Kidney Dis; 1995 Nov; 26(5):740-50. PubMed ID: 7485126
[TBL] [Abstract][Full Text] [Related]
9. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin.
Ohtsuka T; Yamazaki S
Br J Dermatol; 2004 Jun; 150(6):1091-5. PubMed ID: 15214893
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of human parvovirus B19 DNA in cardiac tissues of patients with congenital heart diseases indicated by nested PCR and in situ hybridization.
Wang X; Zhang G; Liu F; Han M; Xu D; Zang Y
J Clin Virol; 2004 Sep; 31(1):20-4. PubMed ID: 15288609
[TBL] [Abstract][Full Text] [Related]
11. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
Niang A; Dial C; Ka EF; Lèye A; Pouye A; Ka MM; Mbengue M; Droz D; Diouf B
Dakar Med; 2008; 53(1):45-51. PubMed ID: 19102117
[TBL] [Abstract][Full Text] [Related]
12. Parvovirus B19 is a bystander in adult myocarditis.
Koepsell SA; Anderson DR; Radio SJ
Cardiovasc Pathol; 2012; 21(6):476-81. PubMed ID: 22425629
[TBL] [Abstract][Full Text] [Related]
13. PNA-based probe for quantitative chemiluminescent in situ hybridisation imaging of cellular parvovirus B19 replication kinetics.
Bonvicini F; Mirasoli M; Gallinella G; Zerbini M; Musiani M; Roda A
Analyst; 2007 Jun; 132(6):519-23. PubMed ID: 17525808
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy.
Yang Y; Gubler MC; Beaufils H
Nephron; 2002 Jul; 91(3):416-23. PubMed ID: 12119471
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections.
Braham S; Gandhi J; Beard S; Cohen B
J Clin Virol; 2004 Sep; 31(1):5-10. PubMed ID: 15288606
[TBL] [Abstract][Full Text] [Related]
16. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR).
Knöll A; Louwen F; Kochanowski B; Plentz A; Stüssel J; Beckenlehner K; Jilg W; Modrow S
J Med Virol; 2002 Jun; 67(2):259-66. PubMed ID: 11992588
[TBL] [Abstract][Full Text] [Related]
17. Detection of parvovirus B19 infection in first and second trimester fetal loss.
de Krijger RR; van Elsacker-Niele AM; Mulder-Stapel A; Salimans MM; Dreef E; Weiland HT; van Krieken JH; Vermeij-Keers C
Pediatr Pathol Lab Med; 1998; 18(1):23-34. PubMed ID: 9566279
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens.
Bonvicini F; Manaresi E; Gallinella G; Gentilomi GA; Musiani M; Zerbini M
BJOG; 2009 May; 116(6):813-7. PubMed ID: 19432570
[TBL] [Abstract][Full Text] [Related]
19. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin.
Cassinotti P; Siegl G; Michel BA; Brühlmann P
J Med Virol; 1998 Nov; 56(3):199-204. PubMed ID: 9783685
[TBL] [Abstract][Full Text] [Related]
20. Parvovirus B19 infection and kidney injury: report of 4 cases and analysis of immunization and viremia in an adult cohort of 100 patients undergoing a kidney biopsy.
Kauffmann M; Bobot M; Daniel L; Torrents J; Knefati Y; Moranne O; Burtey S; Zandotti C; Jourde-Chiche N
BMC Nephrol; 2020 Jul; 21(1):260. PubMed ID: 32646497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
